A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia.
Abstract
Background null Antibody-based strategies for COVID-19 have shown promise in prevention and treatment of early disease. COVID-19 convalescent plasma (CCP) has been widely used but results from randomized trials supporting its benefit in hospitalized patients with pneumonia are limited. Here, we assess the efficacy of CCP in severely ill, hospitalized adults with COVID-19 pneumonia. null Methods null We performed a randomized control trial...
Paper Details
Title
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia.
Published Date
Nov 17, 2021
Pages
17 - 17
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History